CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs – GlobeNewswire (press release)
|
CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs
GlobeNewswire (press release) ZUG, Switzerland and CAMBRIDGE, Mass. and TÜBINGEN, Germany, and BOSTON, Nov. 13, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a genome editing company focused on creating transformative gene-based medicines for … |
